What changed?
A sourced timeline of research records and material development changes tracked by BACToBasics for CJC-1295. Research-publication dates and clinical-development event dates are labeled separately so they are not mistaken for the same type of update.
Tracked items
3
Research sources
2
Development entries
1
Latest recorded date
Published 2026
Latest development activity
Oct 16, 2006 · Program status · Phase 2 (historical / terminated)
ClinicalTrials.gov lists the original DAC-containing CJC-1295 Phase 2 study as terminated. This event does not apply to products marketed as CJC-1295 No DAC / Mod GRF 1-29.
Open source ↗Latest research record by publication date
Published 2026 · Review · Evidence review
The review helps separate direct human evidence for long-acting CJC-1295 from the much weaker evidence base for products marketed as CJC-1295 No DAC / Mod GRF 1-29.
Open source ↗Tracked timeline
Development changes are dated to the underlying milestone. Research-source entries use the study or source publication year currently stored in the Research Library; that year is not presented as the date BACToBasics added the record.
Review · Evidence review
The review helps separate direct human evidence for long-acting CJC-1295 from the much weaker evidence base for products marketed as CJC-1295 No DAC / Mod GRF 1-29.
Program status · Phase 2 (historical / terminated)
ClinicalTrials.gov lists the original DAC-containing CJC-1295 Phase 2 study as terminated. This event does not apply to products marketed as CJC-1295 No DAC / Mod GRF 1-29.
Human intervention · Randomized placebo-controlled human pharmacology
Small controlled human studies showed prolonged GH and IGF-1 effects after the original long-acting CJC-1295 compound.
Following a compound creates a clean baseline from the updates currently known. When BACToBasics later records a new research source or material development change, the My Tools update badge can surface it as new for you.
BACToBasics provides educational research organization only. A development milestone does not predict future approval, and a research record does not establish that a compound is safe, effective, approved, or appropriate for use.